Member Info for BertieBassett

yes ... and although the SP did perk, it didn't zoom.
-- BB --

Until recently, IQAI had two suitors for its SC software. Talks may have broken down with them due to the lack of FDA clearance. That may now be back on the table ... BUT caution says that we will possibly do a quick fundraise (£1m) at 13 - 15 ... and we will see what this Qtr and 1st Qtr 2021 will bring ...
This stock has always been a slow-burner - awaiting the FDA news.
It will perk up again when the inevitable CE is issued.
AI IS the next big thing in medical advances and indeed IQAI is the world leader ...
We still need some patience here.
TB does have a credible history in taking companies to sale at very good multiples.
He also has BRH , RMS etc to work on.
The fact that he owns just under 30% of IQ is why I am here ... he has the most to lose ... and win.
Between 14 and 16 pps is a good place to be for now.
-- BB --

It was a sell.

Trevor has just under 30% of the shares in IQAI .... any predator will need him onside .... unless he is now going over the 30% himself - which I doubt. it looks like he is not in RMS anymore personally.
I still think 50pps is fair value ...
-- BB --

i have been here since the 3pps days ... it's worth 50pps + with all it's IP ... and its obvious future.
not sure it will achieve that this side of Xmas though.
-- BB --

11:35:58 23.131 164,808 38.12k

two suitors ... then one ... then none ...
i believe that the price was not good enough.
could be now!
aiming for 50 pps .... £1 would be glorious.
-- BB --

Just over two years.....
-- BB --

5.94
-- BB --

things have not been as exciting here since ... well ... since the last FDA RNS ....!
-- BB --

Yay.... We got it.

TB "makes" his money over on BRH ... if you look at this share buys/sells for 2020, you can see that ...
I do not question his commitment to IQAI as the team around him are the "scientific" players --- as opposed to him who runs the show ..
(more) Patience is needed!
-- BB --

Bravo lth

Kind info furnished from the chat-site:

This quarter we should receive news on:
IB Stroke
Gad free
SC 2.0
510k liver nodularity
Auto Segmentation
IB Trax

Could land anytime:
Other uses for IB
Grants
Patent
Distribution agreements/ commercial contracts

IB CAD - next year

Earlier this year, a US FDA 510(k) application was submitted for Liver Surface Nodularity (LSN). While the review is still pending, IQ-AI is optimistic it will soon receive clearance.

quiet indeed ... but ... clam before the predicted storm ...
not aiming for 20p ... would be happy with between 9 and 16p ... with 16p being a wedge of cash and great commission payments ... all down to the "partner" in the wings
- BB -

Price paid at 0801 ... !
-- BB --

you will need patience for your patents ...
all good for future patients though ...
-- BB ---

The number of Nil Cost Options shall be adjusted at the completion of the first Reverse Takeover ('RTO') of the Company, being an event marking the first material acquisition made, to such number as to represent 0.4% (decimal four percent) of the issued share capital of the Company following the RTO, subject to the value of the award not exceeding 200% (two hundred percent) of the recipients adjusted base salary at the time of the RTO.

-- in planning?
-- BB --

Yes, there has been much comedy in the past few days with "expert speculation" ...

When Jub Cap is finally out (TR-1?) then it will be a much clearer picture re: SP

The Faroe team was really rather professional and had a plan which was ultimately scuppered by a poor t/o ... am hoping unfinished business will drive LBE along ...

-- BB --